Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Congenital CMV with Cytogam
NCT01376778Phase 3Completed
- Sponsor
- George Washington University Biostatistics Center
- Start
- Apr 2012
- Primary completion
- Oct 2019
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of IgPro10 in cytomegalovirus infection (CMV), sponsored by George Washington University Biostatistics Center. Started Apr 2012; status: completed.
02
Drugs
IgPro10
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT01376778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01376778.